# A Study to Assess the Safety and Anti-Tumor Activity of REGN7945 in Combination With Linvoseltamab in Adult Participants With Relapsed/Refractory Multiple Myeloma

> clinical trial · VERIFIED · 2026-08-05

Status: RECRUITING · Sponsor: Regeneron Pharmaceuticals · Condition: Relapsed/Refractory Multiple Myeloma

- Company: Regeneron Pharmaceuticals
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06669247

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.